{
    "clinical_study": {
        "@rank": "148086", 
        "arm_group": [
            {
                "arm_group_label": "Infant starter formula with synbiotics", 
                "arm_group_type": "Experimental", 
                "description": "Infant starter formula with synbiotics"
            }, 
            {
                "arm_group_label": "Infant formula without synbiotics", 
                "arm_group_type": "Active Comparator", 
                "description": "Infant formula without synbiotics"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary objectives of this trial are:\n\n        -  to show differences in the colonization of the gastrointestinal tract with the bacteria\n           Bifidobacterium sp. between infants born by normal or caesarean delivery, fed with the\n           test or a control product\n\n        -  to investigate whether there is equivalence in growth between the four different groups\n           of infant described above."
        }, 
        "brief_title": "Effect of a Starter Formula With Synbiotics on Stool Microbiota in Infants After Normal or Caesarean Section Delivery", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Healthy Full Term Infants", 
        "detailed_description": {
            "textblock": "The primary objectives of this trial are:\n\n        -  to show differences in the colonization of the gastrointestinal tract with the bacteria\n           Bifidobacterium sp. between infants born by normal or caesarean delivery, fed with the\n           test or a control product\n\n        -  to investigate whether there is equivalence in growth between the four different groups\n           of infant described above.\n\n      Design:\n\n      This is a controlled, double blind, randomized, multi center, clinical trial of 4 groups in\n      parallel.\n\n      Two groups of infants (born from normal or caesarean delivery) will each consume one of 2\n      milk formulae.\n\n      Number of patients (to be enrolled / to be analyzed): Approximately 450 / 240 Stratification\n      will be done by gender and delivery mode.\n\n      Description of subjects and main criteria for inclusion:\n\n      Healthy full term infants born from HIV positive mothers who have elected to feed their\n      child exclusively with a milk formula from birth. Children born after normal or caesarean\n      delivery will be considered separately."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy newborn infant from HIV positive mother\n\n          -  Full term infant (more or equal to 37 weeks gestation; less or equal to 42 weeks\n             gestation)\n\n          -  Age of infant 3 days at the time of enrollment\n\n          -  Birth weight between 2500 and 4500 grams\n\n          -  Singleton birth\n\n          -  The infant's mother has elected to feed their child exclusively with a milk formula\n             from birth\n\n          -  Informed consent from the parent or legal guardian\n\n        Exclusion Criteria:\n\n          -  Congenital illness or malformation that may affect normal growth\n\n          -  Significant pre-natal and / or post-natal disease\n\n          -  Newborns who have received antibiotics during the first 3 days of life\n\n          -  Newborns whose parents / caregivers cannot be expected to comply with the study\n             protocol\n\n          -  Newborns currently participating in another clinical trial"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "3 Days", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "430", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02031887", 
            "org_study_id": "07.19.INF"
        }, 
        "intervention": [
            {
                "arm_group_label": "Infant starter formula with synbiotics", 
                "intervention_name": "formula with synbiotics", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Infant formula without synbiotics", 
                "intervention_name": "formula without synbiotics", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "starter formula", 
            "stool microbiota", 
            "infants", 
            "caesarean section delivery"
        ], 
        "lastchanged_date": "January 7, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Johannesburg", 
                        "country": "South Africa", 
                        "state": "Parktown", 
                        "zip": "2000"
                    }, 
                    "name": "Witswatersrand University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bertsham", 
                        "country": "South Africa", 
                        "zip": "2013"
                    }, 
                    "name": "Chris Hani Baragwanath Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Johannesburg", 
                        "country": "South Africa", 
                        "zip": "2112"
                    }, 
                    "name": "Rahima Moosa Mother and Child Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "South Africa"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of a Starter Formula With Synbiotics on Stool Microbiota in Infants After Normal or Caesarean Section Delivery", 
        "overall_official": {
            "affiliation": "Witswatersrand University", 
            "last_name": "Peter A Cooper", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "South Africa: Medicines Control Council", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "differences in the colonization of the gastrointestinal tract with the bacteria Bifidobacterium sp. between infants born by normal or caesarean delivery, fed with the test or a control product", 
                "safety_issue": "No", 
                "time_frame": "3 days, 10 days, 1 month, and 3 months of age of the infant"
            }, 
            {
                "measure": "\u2022 Mean weight gain (g/day)", 
                "safety_issue": "No", 
                "time_frame": "over 112 days"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02031887"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "body composition by DEXA", 
                "safety_issue": "No", 
                "time_frame": "4 month and 12 month of life"
            }, 
            {
                "measure": "Digestive tolerance (stool characteristics and frequency, vomiting, regurgitation, frequency of colic)", 
                "safety_issue": "No", 
                "time_frame": "10 days, 1 month, 6 weeks, 3 month and 4 month of life"
            }
        ], 
        "source": "Nestl\u00e9", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nestl\u00e9", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2008", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "January 2014", 
        "why_stopped": "South African Health Authorities now promote that HIV positive mothers should receive\n    anti-retroviral drugs and breastfeed their infants."
    }
}